New Jersey-based St. Joseph’s Hospital and Medical Center has purchased a comprehensive PACS from MediSolution. Installation will be completed through the Canadian company’s new MarkCare division, established after acquisition of a company by
New Jersey-based St. Joseph’s Hospital and Medical Center has purchased a comprehensive PACS from MediSolution. Installation will be completed through the Canadian company’s new MarkCare division, established after acquisition of a company by that name. The contract is expected to generate more than CDN $1.5 million in revenue for MediSolution’s MarkCare division over the next three years. In related news, MediSolution has completed its first PACS installation in Canada at Boundary Trails Health Centre, a newly completed medical facility in Winkler, Manitoba.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.